KALA BIO, Inc. (0JQ2.L) LSE
2.45
+0.16(+6.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
KALA BIO, Inc.
Address
1167 Massachusetts Avenue
Arlington, MA 02476
United States of America (the)
Phone
781 996 5252
Website
Sector
Healthcare
Industry
Biotechnology
Employees
38
First IPO Date
January 29, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Avi Minkowitz | CEO, CFO & Director | 0 | 1988 |
| R. Kim Brazzell | Head of R&D and Chief Medical Officer | 703,644 | 1953 |
| Todd Bazemore | Principal Executive Officer & Director | 732,507 | 1970 |
| Mary Reumuth | Treasurer & Secretary | 1.01M | 1975 |
| Josiah Craver | Senior Vice President & Corporate Controller | 0 | N/A |
| Darius Kharabi | Chief Business Officer | 0 | 1980 |
| Vincent Kosewski | Senior Vice President of Manufacturing & Supply Chain Management | 0 | 1963 |
| Patrick Bedell | Executive Director of Trade & Alternate Channels | 0 | N/A |
| Carl Rennie | Executive Director of Account Management | 0 | N/A |
| Justin Hanes | Founder & Chair of the Scientific Advisory Board | 0 | N/A |
| Francis S. Mah | Chief Medical Advisor | 0 | N/A |
| Jill S. Steier | Executive Director of Investor Relations & Corporation Communications | 0 | N/A |
Description
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
